QCM
AURA icon

Quantinno Capital Management’s Aura Biosciences AURA Stock Holding History

Quantinno Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$609K Buy
91,075
+54,694
+150% +$314K ﹤0.01% 2567
2025
Q4 		$198K Sell
36,381
-8,260
-19% -$49K ﹤0.01% 3052
2025
Q3 		$276K Buy
44,641
+22,769
+104% +$149K ﹤0.01% 2524
2025
Q2 		$137K Buy
+21,872
New +$128K ﹤0.01% 2453

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Quantinno Capital Management's AURA Position: Q1 2026 in Review

Quantinno Capital Management increased its Aura Biosciences (AURA) stake by 150% in Q1 2026, buying an estimated $314K and bringing the position to 91,075 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

Quantinno Capital Management first reported a position in AURA in Q2 2025 and has held it in 4 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Quantinno Capital Management held 91,075 shares of Aura Biosciences worth $609K as of Q1 2026.
  • Quantinno Capital Management bought 54,694 Aura Biosciences shares in Q1 2026, an estimated $314K.
  • Aura Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2567 holding.
  • Quantinno Capital Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.